House Rx Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
250
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$55M
- Investors
-
12
House Rx General Information
Description
Operator of a technology-enabled service company intended to make specialty medication more accessible and affordable. The company partners closely with specialty clinics all over the country to deliver combined medical and pharmacy care to all patients, enabling clinics to dispense specialty medications to their patients, physicians, and pharmacists to collaborate on patient care.
Contact Information
Website
www.houserx.comCorporate Office
- 530 Divisadero Street
- Suite 831
- San Francisco, CA 94117
- United States
Corporate Office
- 530 Divisadero Street
- Suite 831
- San Francisco, CA 94117
- United States
House Rx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 12-Nov-2025 | $55M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 14-Mar-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Sep-2021 | $4.91M | $4.91M | Completed | Generating Revenue |
House Rx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 5,596,565 | $0.000010 | 8% | $0.84 | $0.84 | 1x | $0.84 | 11.53% |
| Series A | 7,232,636 | $0.000010 | 8% | $3.43 | $3.43 | 1x | $3.43 | 14.9% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
House Rx Comparisons
Industry
Financing
Details
House Rx Competitors (2)
One of House Rx’s 2 competitors is EVERSANA, a Private Equity-Backed company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EVERSANA | Private Equity-Backed | Chicago, IL | ||||
| Valeris | Private Equity-Backed | Morrisville, NC |
House Rx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
House Rx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
House Rx Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cencora Ventures | Corporate Venture Capital | Minority | ||
| LRVHealth | Venture Capital | Minority | ||
| New Enterprise Associates | Venture Capital | Minority | ||
| Silicon Valley Bank | Corporation | Minority | ||
| Town Hall Ventures | Venture Capital | Minority |
House Rx Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| House Rx Specialty Distribution | Memphis, TN | 2022 |
House Rx FAQs
-
When was House Rx founded?
House Rx was founded in 2021.
-
Where is House Rx headquartered?
House Rx is headquartered in San Francisco, CA.
-
What is the size of House Rx?
House Rx has 250 total employees.
-
What industry is House Rx in?
House Rx’s primary industry is Other Healthcare Services.
-
Is House Rx a private or public company?
House Rx is a Private company.
-
What is the current valuation of House Rx?
The current valuation of House Rx is .
-
What is House Rx’s current revenue?
The current revenue for House Rx is .
-
How much funding has House Rx raised over time?
House Rx has raised $84.9M.
-
Who are House Rx’s investors?
Cencora Ventures, LRVHealth, New Enterprise Associates, Silicon Valley Bank, and Town Hall Ventures are 5 of 12 investors who have invested in House Rx.
-
Who are House Rx’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
